1. Home
  2. CERS vs LAW Comparison

CERS vs LAW Comparison

Compare CERS & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • LAW
  • Stock Information
  • Founded
  • CERS 1991
  • LAW 2013
  • Country
  • CERS United States
  • LAW United States
  • Employees
  • CERS N/A
  • LAW N/A
  • Industry
  • CERS EDP Services
  • LAW Computer Software: Prepackaged Software
  • Sector
  • CERS Technology
  • LAW Technology
  • Exchange
  • CERS Nasdaq
  • LAW Nasdaq
  • Market Cap
  • CERS 324.3M
  • LAW 356.9M
  • IPO Year
  • CERS 1997
  • LAW 2021
  • Fundamental
  • Price
  • CERS $1.58
  • LAW $5.14
  • Analyst Decision
  • CERS Buy
  • LAW Hold
  • Analyst Count
  • CERS 3
  • LAW 5
  • Target Price
  • CERS $3.17
  • LAW $7.10
  • AVG Volume (30 Days)
  • CERS 1.2M
  • LAW 115.3K
  • Earning Date
  • CERS 10-30-2024
  • LAW 02-20-2025
  • Dividend Yield
  • CERS N/A
  • LAW N/A
  • EPS Growth
  • CERS N/A
  • LAW N/A
  • EPS
  • CERS N/A
  • LAW N/A
  • Revenue
  • CERS $176,229,000.00
  • LAW $143,584,000.00
  • Revenue This Year
  • CERS $26.47
  • LAW $5.34
  • Revenue Next Year
  • CERS $11.48
  • LAW $4.77
  • P/E Ratio
  • CERS N/A
  • LAW N/A
  • Revenue Growth
  • CERS 14.71
  • LAW 6.45
  • 52 Week Low
  • CERS $1.38
  • LAW $4.71
  • 52 Week High
  • CERS $2.59
  • LAW $8.80
  • Technical
  • Relative Strength Index (RSI)
  • CERS 38.88
  • LAW 32.88
  • Support Level
  • CERS $1.53
  • LAW $5.77
  • Resistance Level
  • CERS $1.83
  • LAW $5.96
  • Average True Range (ATR)
  • CERS 0.11
  • LAW 0.27
  • MACD
  • CERS -0.03
  • LAW -0.11
  • Stochastic Oscillator
  • CERS 13.89
  • LAW 5.50

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

Share on Social Networks: